Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Human Immunology|May 16, 2006
Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patientsHelmut Rainer Salih, Dennis Goehlsdorf, Alexander Steinle
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Soluble NKG2D ligands: prevalence, release, and functional impactHelmut Rainer Salih, Stefan Holdenrieder, Alexander Steinle
Expert Opinion on Biological Therapy|July 30, 2020
Arming cytotoxic lymphocytes for cancer immunotherapy by means of the NKG2D/NKG2D-ligand systemMariya Lazarova, Winfried S Wels, Alexander Steinle
Plos Pathogens|January 22, 2010
Structure of the HCMV UL16-MICB complex elucidates select binding of a viral immunoevasin to diverse NKG2D ligandsSteffen Müller, Georg Zocher, Alexander Steinle, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
Cutting edge: down-regulation of MICA on human tumors by proteolytic sheddingHelmut R Salih, Hans-Georg Rammensee, Alexander Steinle
Oncoimmunology|December 20, 2013
New prospects on the NKG2D/NKG2DL system for oncologyEvelyn Ullrich, Joachim Koch, Adelheid Cerwenka, et al.
Nature Immunology|October 24, 2006
Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interactionStefan Welte, Sabrina Kuttruff, Inja Waldhauer, et al.
Trends in Immunology|February 19, 2013
Activating natural cytotoxicity receptors of natural killer cells in cancer and infectionJoachim Koch, Alexander Steinle, Carsten Watzl, et al.
Frontiers in Immunology|June 26, 2020
MICAgen Mice Recapitulate the Highly Restricted but Activation-Inducible Expression of the Paradigmatic Human NKG2D Ligand MICAYounghoon Kim, Christina Born, Mathieu Bléry, et al.
Pageof 9